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Associated Factors and Prognostic Implications
of Stimulus-Induced Rhythmic, Periodic, or Ictal Discharges
Sherri A. Braksick, MD; David B. Burkholder, MD; Spyridoula Tsetsou, MD; LaurenceMartineau, MD;
Jay Mandrekar, PhD; Andrea O. Rossetti, MD; Martin Savard, MD;
JeffreyW. Britton, MD; Alejandro A. Rabinstein, MD
IMPORTANCE The implications of stimulus-induced rhythmic, periodic, or ictal discharges
(SIRPIDs) sometimes found on prolonged electroencephalographic (EEG) recordings are
uncertain.
OBJECTIVE To evaluate the incidence of SIRPIDs and their clinical implications in critically ill
patients.
DESIGN, SETTING, AND PARTICIPANTS Amulticenter, international retrospective studywas
performed fromOctober 1, 2012, through September 30, 2014, of consecutive adult patients
hospitalized in intensive care units with alteration of consciousness who underwent EEG
recordings at 3 separate centers. Demographic data, including admission diagnosis, age, sex,
history of epilepsy, and EEG findings, were noted. Characteristics of SIRPIDs were
documented. Data were evaluated for predictors of SIRPIDs and in-hospital mortality. Data
analysis was performed from January 16, 2015, to June 15, 2015.
MAIN OUTCOMES ANDMEASURES Incidence of SIRPIDs, association of SIRPIDs withmortality
and other EEG characteristics, and EEG and clinical predictors of mortality.
RESULTS A total of 416 patients were studied. Themedian age of patients was 60 years
(interquartile range, 46-71 years), and 252 (60.6%) weremale. A total of 104 patients
(25.0%) did not survive to hospital discharge. SIRPIDs were identified in 43 patients (10.3%).
The proportion of patients with SIRPIDs was not significantly different across the 3 sites
(P = .34). Anoxic brain injury (odds ratio [OR], 3.80; 95% CI, 1.73-8.33; P < .001), the use of
antiepileptic medications (OR, 3.24; 95% CI, 1.31-8.00; P = .01), electrographic seizures (OR,
2.85; 95% CI, 1.13-7.19; P = .03), generalized periodic discharges with triphasic morphologic
features (OR, 3.66; 95% CI, 1.67-8.02; P = .001), and sporadic sharp waves and periodic
discharges (OR, 2.59; 95% CI, 1.13-5.92; P = .02) were independently associated with the
presence of SIRPIDs. Older age (OR, 1.02; 95% CI, 1.01-1.04; P = .005), anoxic brain injury
(OR, 3.49; 95% CI, 1.96-6.21; P  .001), and absence of EEG reactivity (OR, 8.14; 95% CI,
4.20-15.79; P < .001) but not SIRPIDs (OR, 1.73; 95% CI, 0.79-3.78; P = .17) were
independently associated with in-hospital mortality.
CONCLUSIONS AND RELEVANCE In critically ill patients undergoing EEG recordings, SIRPIDs
occurred in 43 (10.3%) and were associated with other electrographic abnormalities
previously reported to indicate poor prognosis. However, SIRPIDs were not independently
associated with in-hospital mortality.
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S timulus-induced rhythmic, periodic, or ictal dis-charges (SIRPIDs) are anelectroencephalographic (EEG)finding seen in the critical care setting thatwere first de-
scribed in 2004 (Figure).1 SIRPIDs may be present in 12% to
22%ofpatientsundergoingEEGrecordings inthe intensivecare
unit (ICU).1-3 Identified causes of SIRPIDs include primary ce-
rebral symptoms, such as intracranial hemorrhages,1 neuro-
degenerative diseases,4 and traumatic brain injury,3 and sys-
temic symptoms, such as anoxic brain injury,1-3,5 metabolic
disturbances,1 anddrugtoxicity.6Thepathophysiologicmecha-
nismsandultimate clinical implicationsof SIRPIDs remainun-
certain. Some data suggest that they do not represent an ictal
patternasevidencedbynegative single-photonemissioncom-
puted tomography results7,8; however, clinical improvement
and resolution of SIRPIDs have been reported after treatment
with benzodiazepines.9
Despite an increasing body of data regarding SIRPIDs,
their prognostic value remains unknown, and large studies
evaluating this question are lacking. One study10 that inves-
tigated comatose patients with periodic discharges (PDs),
including SIRPIDs, did not find a difference in outcome or
survival compared with a group of patients without PDs.
A study2 specifically looking at the prognostic utility of
SIRPIDs in comatose patients after cardiac arrest found that
they were associated with mortality when present during
the hypothermic period but not when exclusively seen in the
posthypothermia period. Another study3 found no differ-
ence in outcomes between patients with and without
SIRPIDs. Thus, data on the prognostic significance of
SIRPIDs are limited and conflicting. The aim of this study
was to evaluate the prognostic value of SIRPIDs in critically
ill patients with altered mental status in the ICU at 3 separate
centers.
Methods
We conducted a multicenter, international retrospective re-
viewofpatientshospitalized in the ICUsatL’Enfant-JésusHos-
pital, QuebecCity,Quebec, Canada; LausanneUniversityHos-
pital and Lausanne University, Lausanne, Switzerland; and
Mayo Clinic Hospital, Rochester, Minnesota. The Bureau de
l'éthique de la recherche du CHU de Québec (Quebec), Com-
mission cantonale (VD)d'éthiquede la recherche sur l'êtrehu-
main (Lausanne), andMayoClinic Institutional ReviewBoard
(Rochester) approved the study protocol.
This study comprised consecutive patients admitted to
the participating centers from October 1, 2012, through Sep-
tember 30, 2014. Data analysis was performed from January
16, 2015, to June 15, 2015. Consecutive patients 18 years and
older with an altered level or content of consciousness
(Glasgow Coma Scale score <15 or positive Confusion Assess-
ment Method for the ICU score) admitted to an ICU for any
diagnosis who underwent routine EEG or continuous EEG
monitoring to exclude nonconvulsive seizures were included
in the study.
Data collected included age, sex, history of epilepsy, pri-
mary admitting diagnosis, medications administered during
the EEG recording (including antiepileptics and anesthetics),
lengthofhospitalization,clinicalorelectrographicseizuresdur-
ing hospitalization, andGlasgowOutcomeScale score11 at the
time of hospital discharge.
The EEG recordings were obtained using the interna-
tional 10-20 system and were reviewed for the best back-
ground activity (alpha, beta, theta, delta, or burst suppres-
sion or discontinuous patterns), presence of sporadic sharp
waves and PDs (the latter comprising generalized PDs with-
out triphasic morphologic features and lateralized PDs), gen-
eralized PDs with triphasic morphologic features, reactivity
to stimulation, and presence of SIRPIDs. Reactivity to visual,
auditory, and noxious stimulation was consistently tested
during all recordings. SIRPIDs were defined as rhythmic,
periodic, or ictal discharges that were consistently induced
by alerting stimuli, such as noises, sternal rub, physical
examination, suctioning, turning, and other activities
related to patient care.1 We considered a pattern to be peri-
odic when it consisted of discharges (sharp waves, spikes,
polyspikes, or sharply contoured delta waves) recurring at
regular or nearly regular intervals with an identifiable inter-
discharge interval. If the pattern became continuous, with
no separation between individual discharges, the pattern
was considered rhythmic. In addition, the minimum, maxi-
mum, and mean duration of SIRPIDs and the type of stimu-
lus that elicited the response were noted.
The American Clinical Neurophysiology Society’s 2012
Guidelines12 recommend classifying SIRPIDS under the ru-
bric of stimulus-induced activity and categorizing the type of
stimulus-induceddischarges.We categorized SIRPIDs identi-
fied inour studyas rhythmicdelta activity, PDs, or seizuredis-
charges.Thenumbersof eachsubcategoryofSIRPID typewere
too small to assess their significance individually. As a result,
all SIRPID types were considered in aggregate for statistical
analysis purposes.
Descriptive summaries are reported as mean (SD) or
median (interquartile range [IQR]) for continuous variables
and as frequencies and percentages for categorical variables.
Categorical variables were compared using the χ2 test or
Fisher exact test, and continuous variables were compared
using the 2-sample t test or Wilcoxon rank sum test, as
appropriate. Associations between binary outcomes, such
as SIRPIDs (yes, no), and other predictor variables were
Key Points
Question:Do stimulus-induced rhythmic, periodic, or ictal
discharges (SIRPIDs) have a prognostic value in critically ill patients
with encephalopathy?
Findings: In our population of intensive care unit patients
undergoing electroencephalography, 43 (10.3%) had evidence of
SIRPIDs. Other electroencephalographic abnormalities were also
common in this population.
Meaning: SIRPIDs do not appear to independently predict
mortality, but they often accompanyother electroencephalographic
abnormalities that havepreviously been associatedwith poor
outcomes.
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Figure. Stimulus-Induced Rhythmic, Periodic, or Ictal Discharges (SIRPIDs)
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auditory stim
A 64-year-old comatose womanwith seizures after right subdural hematoma evacuation. Baseline electroencephalogram shows right posterior breach rhythm.
Top, Auditory stimulus results in onset of generalized rhythmic delta activity with triphasic morphologic features. Bottom, Consecutive epoch shows termination of
rhythmic SIRPIDs.
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assessed using univariate and multivariate logistic regres-
sion. Variables with P < .10 were considered candidate vari-
ables for multivariate model building. The magnitude of
association was reported as odds ratio (95% CI). The predic-
tion ability of the final model was quantified using the area
under the receiver operating characteristic curve. All tests
were 2-sided, and P < .05 was considered statistically signifi-
cant. Analysis was performed using SAS statistical software,
version 9.3 (SAS Institute Inc).
Results
A total of 416 patientswere included in the final analysis. The
medianageof thepatientswas60years (IQR,46-71years), and
252 (60.6%)weremale. Sixty-six patientswere enrolled from
Quebec, 205 from Lausanne, and 145 from Rochester. Con-
tinuous (prolonged) EEG recordings were available in 170 pa-
tients (40.9%),whereas short-termEEGrecordingswereavail-
able in 246 (59.1%). One hundred one patients (24.3%) had
previous anoxic brain injury. Forty-threepatients (10.3%)had
aprior history of epilepsy, and 111 patients (26.7%)had a clini-
cal seizureduring their hospitalization.Abnormalities onEEG
testingwere recorded in 394patients (94.7%). Background re-
vealed normal alpha activity in 82 patients (19.7%) and burst
suppression or discontinuous patterns in 36 patients (8.7%).
Periodic discharges without triphasic morphologic features
were seen in 58 patients (13.9%), and PDswith triphasicmor-
phologic featureswereseen in72patients (17.3%).Patientswere
hospitalized for a median of 15 days (IQR, 7.0-29.5 days).
SIRPIDs were identified in 43 patients (10.3%). The inci-
denceofSIRPIDswasnotsignificantlydifferentamongthestudy
sites (8.8%, 15.2%, and 10.3% inQuebec, Lausanne, andRoch-
ester, respectively; P = .34). The proportion of patients with
SIRPIDs identified on short-term EEG recordings was not sig-
nificantlydifferent fromthosewithSIRPIDs identifiedwithcon-
tinuousmonitoring (20 [46.5%]vs 23 [53.5%],P = .10). Among
patients with SIRPIDs, only 7 (16.3%) had normal alpha back-
ground activity. Electroencephalographic background reactiv-
ity (other than SIRPID response) was present in 32 patients
(74.4%)withSIRPIDs.The incitingstimulus inSIRPIDcaseswas
noxious inmost cases (90.7%). SIRPIDspersisted for ameanof
60seconds (IQR,4.5-240.0seconds) andwerecharacterizedas
periodic in23patients (53.5%), rhythmic in 16patients (37.2%),
and ictal in4patients (9.3%).TwelvepatientswithSIRPIDshad
a clinical seizure while hospitalized.
Multiple factors correlated with the presence of SIRPIDs
onunivariate analyses (Table 1). Onmultivariate analysis, an-
oxic brain injury (P < .001), use of antiepileptic medications
(P = .01), electrographic seizures (P = .03), presence of gener-
alizedPDswith triphasicmorphologic features (P = .001), and
sporadic sharpwaves andnontriphasic PDs (P = .02) retained
a significant association with SIRPIDs (Table 2).
ThepresenceandshorterdurationofSIRPIDs,amongother
variables,wereassociatedwithmortality (P = .01)onunivariate
analysis (Table 3). A history of epilepsy (P = .04)was inversely
associatedwithmortality.Onmultivariateanalysis(Table4),older
age(P = .005),anoxicbrain injury(P < .001),andabsenceofEEG
reactivity (P < .001) remainedindependentlyassociatedwith in-
hospitalmortality, but SIRPIDswere not.
Discussion
Thisobservational and retrospective studyofpatientswithen-
cephalopathy in the ICUwhounderwentEEGrecordings found
Table 2. Variables AssociatedWith SIRPIDs onMultivariate Analysis
Variable OR (95% CI) P Value
Anoxic brain injury 3.80 (1.73-8.33) <.001
Use of antiepileptic medications 3.24 (1.31-8.00) .01
Electrographic seizure 2.85 (1.13-7.19) .03
Generalized PDs with triphasic
morphologic features
3.66 (1.67-8.02) .001
Sporadic sharp waves and PDs 2.59 (1.13-5.92) .02
Abbreviations: OR, odds ratio; PD, periodic discharge;
SIRPIDs, stimulus-induced rhythmic, periodic, or ictal discharges.
Table 1. Variables AssociatedWith SIRPIDs on Univariate Analysisa
Variable
SIRPIDs
(n = 43)
No SIRPIDs
(n = 373) P Value
Age, median (IQR), y 64.0 (52-78) 59.0 (45-70) .03
Anoxic brain injury 16 (37.2) 85 (22.8) .06
In-hospital mortality 18 (41.9) 86 (23.1) .01
Generalized PDs with triphasic
morphologic features
14 (32.6) 58 (15.5) .01
Sporadic sharp waves and PDs 25 (58.1) 83 (22.3) <.001
Absence of EEG reactivity 11 (25.6) 56 (15.0) .08
Burst suppression or discontinuous patterns 2 (4.7) 34 (9.1) .56
PDs alone 15 (34.9) 43 (11.5) <.001
History of epilepsy 2 (4.7) 41 (11.0) .29
Clinical seizure during hospitalization 12 (27.9) 99 (26.5) .85
Electrographic seizure 13 (30.2) 30 (8.0) <.001
Use of antiepileptic medication 34 (79.1) 185 (49.6) <.001
Use of anesthetic medication 25 (58.1) 197 (52.8) .52
Abbreviations: EEG,
electroencephalographic;
IQR, interquartile range; PD, periodic
discharge; SIRPIDs, stimulus-induced
rhythmic, periodic, or ictal
discharges.
a Data are presented as number
(percentage) of patients unless
otherwise indicated.
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that in-hospital mortality was associated with older age, an-
oxic brain injury, and absent reactivity onEEG testing but not
with the presence of SIRPIDs. SIRPIDsweremore common in
patients who died in the hospital (17.3% vs 8.0% in survi-
vors), but this association was not significant when adjusted
for other prognostic factors.
In our population, SIRPIDs were present in 43 patients
(10.3%). Distinct epileptiform abnormalities commonly co-
occurred with SIRPIDs, which may indicate an epileptogenic
potential of SIRPIDs. Antiepileptic therapy is commonlyused
in patients with SIRPIDs and discharges considered epilepti-
form, but the utility of suppressing SIRPIDs in these patients
remains uncertain.
The duration of SIRPIDswas shorter in patientswho died
in the hospital comparedwith thosewho survived. This find-
ing argues against thenotion that theseEEG featuresmay rep-
resentan ictalpatternbecauseonemightanticipatehighermor-
tality and other poor outcomes to be associated with a
prolongeddurationofdischargesdespite treatment, along the
lines of refractory status epilepticus.13-15 It is probable that a
spectrumofneuronal injury is responsible for theneurophysi-
ologic changes of SIRPIDs, which may be considered less se-
vere or potentially reversible in some circumstances.2 This
finding may be reflected by the different types of SIRPIDs
(ie, rhythmic, periodic, or ictal).
Patients with a preexisting diagnosis of epilepsy or an in-
hospital seizurewere less likely todie in thehospital in our co-
hort.Previousstudies16,17have foundthatpatientswithknown
epilepsy have improved outcomes in status epilepticus com-
pared with patients with acute disease, and, consequently,
apreviousdiagnosisofepilepsyhasbeen incorporated intosta-
tus epilepticus severity andmortality scales as a favorable fac-
tor relative to acute disease. The improved survival noted in
patientswithclinical seizures ismore surprisingbecause these
seizureswere not solely seen in patientswith preexisting epi-
lepsy. It is possible that the presence of seizures led to amore
aggressive antiepileptic treatment, or, alternatively, patients
with seizures may have been encephalopathic because of a
postictal state rather than because of non–seizure-related
causes associated with worse prognosis. Electrographic sei-
zures were not associated with mortality, whereas epilepti-
form discharges were. This finding was somewhat unex-
pected, but a reasonable explanation could be that a greater
preservation of neuronal circuitry is necessary for electro-
graphic seizures tooccur; hence, seizuresmay indicate less se-
vere cerebral injury.
Our study confirms the importance of several prognostic
factors,most notably the lack of EEG reactivity. Although any
significantly abnormalEEGfindingsmaybeprognosticallyun-
favorable, the ability to sustain EEG reactivity after stimula-
tion, even when aberrant, indicates less severe cerebral in-
jury and, consequently, an improved chance of survival. This
finding alignswith the observation that patientswith normo-
thermia with preserved EEG reactivity have more favorable
short-term outcome.18
This study has limitations. The observational and retro-
spective nature of data collection made the degree of func-
tional impairmentdifficult to fully characterize in somecases;
Table 3. Variables AssociatedWith In-Hospital Mortality on Univariate Analysisa
Variable
Died
(n = 104)
Survived
(n = 312) P Value
Age, median (IQR), y 63.5 (55-76) 58.0 (43-69) .001
Anoxic brain injury 49 (47.1) 52 (16.7) <.001
Presence of SIRPIDs 18 (17.3) 25 (8.0) .01
Duration of SIRPIDs, median (IQR), s 5.3 (2-60) 142 (40-345) .002
Maximum SIRPID duration, median (IQR), s 5.5 (2-180) 275 (30-900) <.001
Minimum SIRPID duration, median (IQR), s 6 (2-15) 39 (14-64) .004
Generalized PDs with triphasic
morphologic features
22 (21.2) 50 (16.0) .23
Sporadic sharp waves and PDs 40 (38.5) 68 (21.8) .001
Absence of EEG reactivity 44 (42.3) 23 (7.4) <.001
Burst suppression or discontinuous patterns 22 (21.2) 14 (4.5) <.001
PDs alone 17 (16.3) 41 (13.1) .42
History of epilepsy 5 (4.8) 38 (12.2) .04
Clinical seizure during hospitalization 16 (15.4) 95 (30.4) .003
Electrographic seizure 11 (10.6) 32 (10.3) .66
Use of antiepileptic medication 55 (52.9) 164 (52.6) >.99
Use of anesthetic medication 63 (60.6) 159 (51.0) .11
Abbreviations: EEG,
electroencephalographic;
IQR, interquartile range; PD, periodic
discharge; SIRPIDs, stimulus-induced
rhythmic, periodic, or ictal
discharges.
a Data are presented as number
(percentage) of patients unless
otherwise indicated.
Table 4. Variables AssociatedWith In-Hospital Mortality
onMultivariate Analysis
Variable OR (95% CI) P Value
Older age 1.02 (1.01-1.04) .005
Anoxic brain injury 3.49 (1.96-6.21) <.001
Burst suppression or
discontinuous patterns
1.36 (0.55-3.36) .51
SIRPIDs 1.73 (0.79-3.78) .17
Absence of EEG reactivity 8.14 (4.20-15.79) <.001
Abbreviations: OR, odds ratio; EEG, electroencephalographic;
SIRPIDs, stimulus-induced rhythmic, periodic, or ictal discharges.
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thus,weoptedto include in-hospitalmortalityas theonlyclini-
cal endpoint. Given the 3-site design andmultiple epileptolo-
gists (D.B.B., A.O.R., M.S., and J.W.B.) who reviewed the EEG
recordings, theremay have been variability in the interpreta-
tionof EEG findings; however, no significant difference in the
incidence of SIRPIDs among siteswas noted. The type of EEG
recording obtained (short-term vs continuous) may have re-
sulted in some episodes of SIRPIDs being overlooked if only a
short-term recording was performed. Given the small num-
ber of patients who experienced SIRPIDs, further evaluation
of the clinical and prognostic implications of each subtype of
SIRPID was unable to be confidently completed.
Conclusions
SIRPIDs occurred in 43 patients (10.3%)with encephalopathy
in the ICU examinedwith EEG recordings. Generally, SIRPIDs
wereaccompaniedbyotherEEGabnormalities, includingelec-
trographic seizures and epileptiform discharges. Although
SIRPIDs were more common in patients who did not survive
thehospitalization, their presencewasnot independently as-
sociatedwith in-hospitalmortality.Older patients, thosewith
anoxic brain injury, and those without EEG reactivity were
more likely to die in the hospital.
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